316.55 10.25 (3.35%)

3.3M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

US FDA Approval
Biocon receives USFDA approval for Jobevne, used in cancer treatment, with a market size of ~$2 bn See details


Board Meetings - Biocon Ltd.

The next board meeting for Biocon Ltd. is on 08 May 2025 for the purpose of Audited Results & Final Dividend

Ex-date Purpose Notes
08 May 2025 Audited Results & Final Dividend -
04 Apr 2025 To consider Fund Raising -
30 Jan 2025 Quarterly Results & Others To consider other business matters.
27 Jan 2025 Others Inter-alia, to consider 1. Raising of Funds through issuance of Commercial Papers (CPs) or through any other mode on private placement basis.
30 Oct 2024 Quarterly Results -
08 Aug 2024 Quarterly Results -
16 May 2024 Audited Results & Final Dividend -
08 Feb 2024 Quarterly Results -
10 Nov 2023 Quarterly Results -
10 Aug 2023 Quarterly Results -
23 May 2023 Audited Results & Final Dividend -
26 Apr 2023 Others To consider, Fund Raising.
14 Feb 2023 Quarterly Results -
14 Nov 2022 Quarterly Results -
27 Jul 2022 Quarterly Results -
28 Apr 2022 Audited Results & Dividend -
20 Jan 2022 Quarterly Results -
21 Oct 2021 Quarterly Results -
22 Jul 2021 Quarterly Results -
28 Apr 2021 Audited Results & Final Dividend -
21 Jan 2021 Quarterly Results -
22 Oct 2020 Quarterly Results -
23 Jul 2020 Quarterly Results -
14 May 2020 Audited Results -
23 Jan 2020 Quarterly Results -
23 Oct 2019 Quarterly Results -
25 Jul 2019 Quarterly Results -
25 Apr 2019 Audited Results, Dividend & Bonus -
24 Jan 2019 Quarterly Results -
25 Oct 2018 Quarterly Results -
26 Jul 2018 Quarterly Results -
26 Apr 2018 Audited Results & Final Dividend -
24 Jan 2018 Quarterly Results -
26 Oct 2017 Quarterly Results -
27 Jul 2017 Quarterly Results -
27 Apr 2017 Audited Results, F. Dividend & Bonus -
24 Jan 2017 Quarterly Results -
20 Oct 2016 Quarterly Results -
21 Jul 2016 Quarterly Results & Others The Company will organize a conference call for analysts and investors on July 22, 2016.
26 Apr 2016 Audited Results -
11 Mar 2016 Interim Dividend -
21 Jan 2016 Quarterly Results -
20 Oct 2015 Quarterly Results -
23 Jul 2015 Quarterly Results -
29 Apr 2015 Audited Results -
22 Jan 2015 Quarterly Results -
21 Oct 2014 Quarterly Results -
24 Jul 2014 Quarterly Results -
24 Apr 2014 Audited Results & Dividend -
22 Jan 2014 Quarterly Results -
24 Oct 2013 Quarterly Results -
25 Jul 2013 Quarterly Results -
25 Apr 2013 Audited Results & Dividend -
24 Jan 2013 Quarterly Results -
30 Oct 2012 Quarterly Results -
25 Jul 2012 Quarterly Results & Merger To Consider merger of Biocon Biopharmaceuticals Limited; a wholly owned subsidiary with the Company.
26 Apr 2012 Audited Results & Dividend -
24 Jan 2012 Quarterly Results -
19 Oct 2011 Quarterly Results (Revised)
21 Jul 2011 Quarterly Results -
28 Apr 2011 Aud. Results, Dividend & Intm. Dividend -
20 Jan 2011 Quarterly Results -
22 Oct 2010 Quarterly Results -
23 Jul 2010 Quarterly Results -
29 Apr 2010 Audited Results & Dividend -
21 Jan 2010 Quarterly Results -
22 Oct 2009 Quarterly Results -
23 Jul 2009 Quarterly Results -
28 Apr 2009 Audited Results & Dividend -
21 Jan 2009 Quarterly Results -
17 Jul 2008 Quarterly Results -
22 Apr 2008 Aud. Results, Dividend & Bonus Issue -
17 Jan 2008 Quarterly Results -
18 Oct 2007 Quarterly Results -
18 Jul 2007 Quarterly Results -
19 Apr 2007 Accounts & Dividend -
18 Jan 2007 Quarterly Results -
18 Oct 2006 Quarterly Results -
19 Jul 2006 Quarterly Results -
20 Apr 2006 Accounts & Dividend -
18 Jan 2006 Quarterly Results -
19 Oct 2005 Quarterly Results -
20 Jul 2005 Quarterly Results -
20 Apr 2005 Dividend & Accounts -
20 Jan 2005 Quarterly Results -
14 Jul 2004 Accounts -
14 May 2004 Accounts & Dividend -